| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | Mar 25, 2025 | Trevi Therapeutics, Inc. | CEO | Sell | 26.3 | -5,263 | -2.41% | ✗ | $34.6K |
| Sep 17, 2024 | Sep 19, 2024 | RHYTHM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -31,751 | -91.37% | ✓ | $1.7M |
| Sep 9, 2024 | Sep 11, 2024 | RHYTHM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -37,241 | -92.54% | ✓ | $1.9M |
| Sep 6, 2024 | Sep 9, 2024 | Trevi Therapeutics, Inc. | CEO | Sell | 26.3 | -6,059 | -1.40% | ✗ | $18.4K |
| Sep 3, 2024 | Sep 5, 2024 | Trevi Therapeutics, Inc. | CEO | Sell | 22.5 | -55,121 | -7.93% | ✗ | $170.2K |
| Aug 26, 2024 | Aug 28, 2024 | RHYTHM PHARMACEUTICALS, INC. | Director | Sell | 7.5 | -14,508 | -82.86% | ✓ | $725.5K |
| May 20, 2024 | May 22, 2024 | Trevi Therapeutics, Inc. | CEO | Sell | 22.5 | -25,037 | -10.50% | ✗ | $71.6K |
| May 10, 2024 | May 14, 2024 | Trevi Therapeutics, Inc. | CEO | Sell | 26.3 | -4,578 | -2.10% | ✗ | $13.3K |
| May 9, 2019 | May 13, 2019 | Trevi Therapeutics, Inc. | Officer | Buy | 90.0 | +11,250 | 5.77% | ✗ | $112.5K |